In this episode of the GSA Momentum Discussions Podcast, Rodolfo Galindo, MD, discusses once-weekly basal insulin therapy for adults with type 2 diabetes. He explores the scientific rationale for reducing basal injection frequency, reviews key clinical findings, examines safety and patient-selection considerations, and discusses how this emerging option may fit into individualized diabetes care.
Support provided by Novo Nordisk.